Rovista Tablets

Rovista Tablets – Potent Lipid-Lowering Therapy

Rovista is a highly effective anti-lipidemic medication containing Rosuvastatin, designed to manage high levels of fats in the blood. It is primarily indicated for the treatment of hyperlipidemia and mixed dyslipidemia in adult patients. The medication serves as an essential adjunctive therapy to a heart-healthy diet, aiming to reduce several harmful lipid markers, including Total-C, LDL-C, and triglycerides. Additionally, Rovista works to increase levels of HDL (the "good") cholesterol, promoting a more balanced and healthy lipid profile.

Beyond adult care, Rovista is indicated for pediatric patients aged 10 to 17 years who suffer from heterozygous familial hypercholesterolemia (HeFH). In these young patients, it is used when dietary modifications alone are insufficient to lower significantly elevated LDL levels. By managing these fats early, Rovista helps prevent the long-term buildup of plaque in the arteries, a process known as atherosclerosis. Reducing this buildup is critical for protecting the heart and brain from future cardiovascular events like strokes and heart attacks. The tablets provide consistent 24-hour control with a single daily dose.

• Treats hyperlipidemia and mixed dyslipidemia in adults.
• Indicated for pediatric patients with familial hypercholesterolemia.
• Reduces "bad" cholesterol and increases "good" cholesterol.
• Available as: Tablets 5mg, 10mg, and 20mg.